Atara Biotherapeutics (ATRA) Other Working Capital Changes (2013 - 2026)
Atara Biotherapeutics (ATRA) reported Other Working Capital Changes of -$285000.0 for Q1 2026, down 3462.5% on a YoY basis from $8475.8 in Q1 2025, and down 3266.67% quarter-over-quarter from $9000.0 in Q2 2025.
Atara Biotherapeutics (ATRA) Other Working Capital Changes (2013 - 2026) Analysis & Trends
Atara Biotherapeutics has reported Other Working Capital Changes for 14 years, with the latest figure at -$285000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes fell 3462.5% year-over-year to -$285000.0; the trailing twelve-month figure through Mar 2026 stood at -$276000.0 (down 922.22% YoY), and the FY2025 full-year result was $1000.0, up 100.22% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$285000.0, down from $9000.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was $7.6 million in Q4 2024, with the low at -$13.2 million in Q4 2023.
- Historically, Other Working Capital Changes has averaged -$1.4 million across 5 years, with a median of -$443000.0 in 2024.
- Annual changes were most pronounced in 2023 — Other Working Capital Changes jumped 559.69% — and 2026, when it plunged 3462.5%.
- Atara Biotherapeutics' Other Working Capital Changes stood at -$1.2 million in 2022, then slumped by 972.96% to -$13.2 million in 2023, then surged by 157.68% to $7.6 million in 2024, then plunged by 99.88% to $9000.0 in 2025, then sank by 3266.67% to -$285000.0 in 2026.
- The last three Other Working Capital Changes figures came in at -$285000.0 (Q1 2026), $9000.0 (Q2 2025), and -$8000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Atara Biotherapeutics | 134.61 Mn | 126.21 Mn | 392,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -285,000.00 |
| Mar 31, 2026 | -285,000.00 |
| Jun 30, 2025 | 9,000.00 |
| Jun 30, 2025 | 9,000.00 |
| Mar 31, 2025 | -8,000.00 |
| Mar 31, 2025 | -8,000.00 |
| Dec 31, 2024 | 7.60 Mn |
| Dec 31, 2024 | 7.60 Mn |
| Sep 30, 2024 | -816,000.00 |
| Sep 30, 2024 | -816,000.00 |
| Jun 30, 2024 | -6.80 Mn |
| Jun 30, 2024 | -6.80 Mn |
| Mar 31, 2024 | -443,000.00 |
| Mar 31, 2024 | -443,000.00 |
| Dec 31, 2023 | -13.18 Mn |
| Dec 31, 2023 | -13.18 Mn |
| Sep 30, 2023 | 7.56 Mn |
| Sep 30, 2023 | 7.56 Mn |
| Jun 30, 2023 | -9.99 Mn |
| Jun 30, 2023 | -9.99 Mn |